Cynergistek, Inc. provides outsourced document solutions, IT consulting data security, and managed print services primarily to the healthcare industry in the United States. The company offers Incident Response, Vendor Security Management, and Patient Privacy Monitoring Service, as well as Compliance Assist Partner Program. It also serves financial institutions, and gaming and other industries. The company was formerly known as Auxilio, Inc. and changed its name to Cynergistek, Inc. in September 2017. Cynergistek, Inc. is based in Mission Viejo, California.
Industry, Sector and Symbol
Stock Exchange NYSEAMERICAN
Industry Diversified Machinery
Sub-IndustryN/A
SectorIndustrial Products
Current SymbolNYSEAMERICAN:CTEK
Previous SymbolNYSEMKT:CTEK
CUSIPN/A
Phone949-614-0700
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees302
Outstanding Shares9,620,000
Market Cap$0.00
OptionableNot Optionable
CynergisTek (NYSEAMERICAN:CTEK) Frequently Asked Questions
What is CynergisTek's stock symbol?
CynergisTek trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CTEK."
How were CynergisTek's earnings last quarter?
CynergisTek Inc (NYSEAMERICAN:CTEK) posted its earnings results on Wednesday, November, 7th. The company reported $0.23 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.14 by $0.09. The company earned $19.22 million during the quarter, compared to analysts' expectations of $18.65 million. View CynergisTek's Earnings History.
When is CynergisTek's next earnings date?
What price target have analysts set for CTEK?
2 Wall Street analysts have issued 1 year target prices for CynergisTek's stock. Their predictions range from $7.20 to $8.25. On average, they anticipate CynergisTek's share price to reach $7.7250 in the next year. This suggests a possible upside of 61.9% from the stock's current price. View Analyst Price Targets for CynergisTek.
What is the consensus analysts' recommendation for CynergisTek?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CynergisTek in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CynergisTek.
Has CynergisTek been receiving favorable news coverage?
Media stories about CTEK stock have been trending somewhat positive on Sunday, according to InfoTrie Sentiment. InfoTrie rates the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. CynergisTek earned a news sentiment score of 0.8 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days.
Who are some of CynergisTek's key competitors?
Some companies that are related to CynergisTek include Alstom (ALO), Associated British Engineering (ASBE), Castings (CGS), Chamberlin (CMH), Continental Materials (CUO), dynaCERT (DYA), Goodwin (GDWN), GUD (GUD), International Corona Capital (IC), Melrose Industries (MRO), Northbridge Industrial Services (NBI), Smiths Group (SMIN), Tricorn Group (TCN), Velan (VLN) and Weir Group (WEIR).
Who are CynergisTek's key executives?
CynergisTek's management team includes the folowing people:
- Mr. Michael H. McMillan CISM, FHIMSS, CEO, Pres, Chief Strategy Officer & Director (Age 61)
- Mr. Paul T. Anthony, CFO, Corp. Sec. & Treasurer (Age 47)
- Mr. Bryan Flynn, Head of Investor Relations
- Mr. Jon Hilfiger, Sr. VP of Sales & Marketing
- Dr. Michael G. Mathews, Chief Operating Officer and Director (Age 49)
Who are CynergisTek's major shareholders?
CynergisTek's stock is owned by a variety of of retail and institutional investors. Top institutional investors include ARS Investment Partners LLC (4.81%), Bridgeway Capital Management Inc. (1.70%) and Vanguard Group Inc. (1.02%). View Institutional Ownership Trends for CynergisTek.
Which major investors are buying CynergisTek stock?
How do I buy shares of CynergisTek?
Shares of CTEK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CynergisTek's stock price today?
One share of CTEK stock can currently be purchased for approximately $4.77.
What is CynergisTek's official website?
How can I contact CynergisTek?
The company can be reached via phone at 949-614-0700.
MarketBeat Community Rating for CynergisTek (NYSEAMERICAN CTEK)
MarketBeat's community ratings are surveys of what our community members think about CynergisTek and other stocks. Vote "Outperform" if you believe CTEK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CTEK will underperform the S&P 500 over the long term. You may vote once every thirty days.
